“Anti Drug Conjugates represent a new way of treating thoracic, breast and gastrointestinal cancers.
Despite recent successes, many ADCs failed during clinical development due to excessive toxicities and unfavorable risk-benefit profiles.
In this episode of Lung Cancer Considered, host Narjust Florez discusses ADCs, and how clinicians can manage some of these toxicities.
With Benjamin Levy and Paolo Tarantino.”